← Back to Clinical Trials
Recruiting NCT07677969

NCT07677969 The Relationship Between Lost Extremity Percentage and Postural Control, Neck and Low Back Pain, Daily Living Activities, and Reaction Time in Individuals With Unilateral Upper Limb Amputation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07677969
Status Recruiting
Phase
Sponsor Hacettepe University
Condition Upper Limb Amputation
Study Type OBSERVATIONAL
Enrollment 15 participants
Start Date 2026-01-01
Primary Completion 2026-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
This is an observational study. No interventional procedures are performed. All assessments are non-invasive measurements.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 15 participants in total. It began in 2026-01-01 with a primary completion date of 2026-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational study aims to examine the relationship between the percentage of limb loss and functional outcomes in individuals with unilateral upper limb amputation. Upper limb amputation can affect posture, balance control, pain levels, daily living activities, hand function, and reaction time. However, limited research has investigated how the amount of limb loss influences these outcomes. Participants between 18 and 65 years of age who use a myoelectric or bionic prosthesis will undergo a series of assessments. These assessments include measurements of postural control using a force platform, posture analysis, evaluation of neck and low back pain using a visual analog scale, daily living activities using a validated questionnaire, hand dexterity using the Box and Block Test, and reaction time using a visual stimulus device. The study does not involve any intervention or treatment. All evaluations will be performed during a single assessment session. The results of this study may help improve rehabilitation planning and provide better understanding of functional changes associated with different levels of limb loss in people with upper limb amputation.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18-65 years * Unilateral upper limb amputation * Use of a myoelectric or bionic prosthesis for at least 1 year * Current prosthesis use for a minimum of 3 months Exclusion Criteria: * Bilateral upper limb amputation * Additional amputation of another limb * Use of passive or cosmetic prosthesis * Presence of neurological or other significant orthopedic disorders unrelated to amputation

Contact & Investigator

Central Contact

ASLI BEBEK, MSc

✉ aslisabanci97@gmail.com

📞 +905364037230

Frequently Asked Questions

Who can join the NCT07677969 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Upper Limb Amputation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07677969 currently recruiting?

Yes, NCT07677969 is actively recruiting participants. Contact the research team at aslisabanci97@gmail.com for enrollment information.

Where is the NCT07677969 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07677969 clinical trial?

NCT07677969 is sponsored by Hacettepe University. The trial plans to enroll 15 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology